Showing results (41-50 of 123) with videos related to
Sort By:
Pageof 13
Rheumatology (Oxford, England)|August 24, 2016
Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritisErnest Choy, Daniel Aletaha, Frank Behrens, et al.Rheumatology (Oxford, England)|August 27, 2020
Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritisAndrea Rubbert-Roth, Daniel Aletaha, Jenny Devenport, et al.Journal of Neurology|June 18, 2010
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosisHela-Felicitas Petereit, Dirk Reske, Hayrettin Tumani, et al.Leukemia & Lymphoma|June 29, 2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphomaDeniz Kahraman, Sebastian Theurich, Achim Rothe, et al.International Journal of Cancer|September 2, 2024
Humoral immune response as an indicator for protection against Covid-19 after anti-SARS-COV2-booster vaccination in hematological and oncological patientsDieter Mainka, Nathalie Bauer, Lutz Dietze, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2008
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infectionNorma Jung, Clara Lehmann, Andrea Rubbert, et al.Arthritis Research & Therapy|January 14, 2018
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world settingRieke Alten, Harald Burkhardt, Eugen Feist, et al.RMD Open|June 3, 2016
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumabAndrea Rubbert-Roth, Anthony Sebba, Laura Brockwell, et al.Rheumatology (Oxford, England)|May 14, 2010
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)Andrea Rubbert-Roth, Paul P Tak, Cristiano Zerbini, et al.Arthritis Research & Therapy|August 25, 2022
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumabAndrea Rubbert-Roth, Daniel E Furst, Stefano Fiore, et al.Pageof 13